Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Noreen Spendlove was 68 when she developed pain in her left side
GP referred Noreen for a mammogram which revealed three tumours
MPs warn that women will die as a result of the screening age limit
'Extending the age for routine mammograms would mean more lives saved'
In the late 1800s, a New York surgeon named William Coley noticed that some patients with cancer seemed to fare better if they developed an ...
Cancer immunotherapy seeks to harness the body's natural immune responses to direct them more effectively against cancer cells. The body does ...
This type of treatment -- also known as cancer immunotherapy -- uses a person's immune system to fight cancer. The viruses are being engineered to ...
The clinical trial, KEYNOTE-046, is the first-in-human study of Advaxis's lead Lm-LLOimmunotherapy candidate for prostate cancer. It is the second ...
KEYNOTE-046 is the second trial initiated to evaluate KEYTRUDA, and the first-in-human study of ... -PipelineReview.com (press release)
In an interview with OncLive, Sundar Jagannath, MD, director of the Multiple Myeloma Program at the Tisch Cancer Institute, professor of Medicine ...
Cancer immunotherapy is characterized by the use of the body's own immune system to help fight cancer. One immunotherapy strategy is based on ...
Vials containing biological samples are stored on ice to keep them fresh before being analyzed at the Cancer Research UK Cambridge Institute on ...
Having a good immune system is essential in fighting head and neck cancer. As it turns out, researchers and physicians at Sylvester Comprehensive ...
"Many researchers have hypothesized that it would be possible to use neoantigens to broadly activate the human immune system, but we didn't know ...
Scientists at the University of Miami identified the chemical that stops cancer cells from inhibiting your immune system. That same chemical is found in ...
... of natural DNA components, stimulates the human immune system to fight infections and attack cancer cells without causing the harmful side effects ...
St. Luke's Cancer Center offers new Phase II oncolytic viral therapy clinical trial for advanced ...
St. Luke's Cancer Center is a leader in offering clinical trials for patients with ... “We began to look at the immune system and target cells that attack ...
... molecules called ImmTACs (Immune mobilising mTCR Against Cancer) that enable the immune system to recognise and kill cancerous cells.
Resisting Cancer
If one out of three people develops cancer, that means two others don’t. Understanding why could lead to insights relevant to prevention and treatment.
That's a big reason pancreatic cancer will become the second-leading cause of cancer death in the U.S. within five years, surpassing both breast and ...
Launch of Project Survival: Collaboration Aims to Uncover First Ever Biomarker for Pancreatic Cancer - PR Web (press release)
Source: Cancer Research UK Cancer Research UK scientists have discovered that a vital self-destruct switch in cells is hijacked - making some ...
Evidence from animal studies also showed a link between glyphosate and rare kidney and pancreatic cancers. Cell studies showed abnormal ...
... many cancers - including nearly all pancreatic cancers - enslave and deform mitochondria, the powerhouses of cells, to create an environment more ...
OBJECTIVE: To review the current knowledge on risk assessment and prediction tools to enhance clinical decision making and counseling of patients ...
BRCA-Associated Cancer Risk May Vary by Mutation Type
Researchers have used observational study data to better define risks for breast and ovarian cancers associated with mutations in the BRCA1 or BRCA2 genes.
Researchers have used observational study data to better define risks for breast and ovarian cancers associated with mutations in the BRCA1 or BRCA2 genes.
Interferon Could Help CML Patients Stop TKI Therapy
Results from a small study suggest that treatment with interferon alpha 2a could help chronic myeloid leukemia patients discontinue imatinib treatment.
Results from a small study suggest that treatment with interferon alpha 2a could help chronic myeloid leukemia patients discontinue imatinib treatment.
Bosutinib a Good Fourth-Line Option in CML
A small retrospective study of heavily pretreated patients with chronic myeloid leukemia found bosutinib to be a good option in the fourth-line setting.
A small retrospective study of heavily pretreated patients with chronic myeloid leukemia found bosutinib to be a good option in the fourth-line setting.
SBRT Offers Short-Term Improvements Over Surgery in Early-Stage NSCLC
Though surgery is the standard treatment for early-stage non-small-cell lung cancer, a new study suggests that stereotactic body radiotherapy (SBRT) offers lower immediate mortality and toxicity. Over the longer term, however, there is benefit with surgery over SBRT.
Though surgery is the standard treatment for early-stage non-small-cell lung cancer, a new study suggests that stereotactic body radiotherapy (SBRT) offers lower immediate mortality and toxicity. Over the longer term, however, there is benefit with surgery over SBRT.
Science Daily Cancer News
A neuro-oncology research team recently identified the transcription factor Id4 as a suppressor of tumor cell invasion in glioblastoma. "This finding suggests a novel therapeutic target to decrease invasion of tumor cells in patients and may also provide a novel biomarker that could help predict survival of patients with glioblastoma," explained a researcher.
A new discovery could offer more effective drugs to combat brain tumors, scientists report. The study found that a subset of glioblastoma tumor cells is dependent on a particular enzyme that breaks down the amino acid glycine. Without this enzyme, toxic metabolic byproducts build up inside the tumor cells, and they die.
The ability of tumor cells to form tubular networks that mimic blood vessels can help drive metastasis, the spread of breast cancer to different sites in the body, a mouse model study has demonstrated. The researchers are now examining what it takes for tumor cells that have exited from a primary tumor into the bloodstream to then get out of the bloodstream and colonize a new site in the body. "We've identified some interesting targets that we think seem to be key for this step," researcher says.
The Fountain of Youth has been discovered and it's not in Florida as Ponce de Leon claimed. Instead, it was found in the mammary glands of genetically modified mice. A research team has found that when two factors that control tissue development are removed, you can avoid the impact of aging.
Scientists are mapping the habits of cancer cells, turn by microscopic turn. Using advanced technology and an approach that merges engineering and medicine, a team has compiled some of the most sophisticated data yet on the elaborate signaling networks directing highly invasive cancer cells. Think of it as a digital field guide for a deadly scourge.
A large prospective study of lung cancer found no strong associations between lung cancer risk and a wide range of reproductive history variables and only revealed weak support for a role of hormone use in the incidence of lung cancer
Researchers list reasons why the U. S. Surgeon General should announce that UV tanning causes skin cancer
A July, 2014 Call to Action to Prevent Skin Cancer by acting Surgeon General Dr. Boris Lushniak points out that indoor tanning is "strongly associated with increased skin cancer risk," but stops short of reporting that tanning causes cancer. A new opinion article points out that UV tanning meets the same criteria as smoking as a cause of cancer and argues that announcing the causality could save lives.
The loss of key gene, WAVE1 has been linked by researchers to a lethal form of prostate cancer, according to a study. Using bioinformatic meta-analysis to compare several publicly available databases, researchers found that alterations in the WAVE1 gene were associated with a shorter period of remission in patients who were treated for prostate cancer. Strikingly, the study also showed that 22.9 percent of the prostate cancers reviewed in the database harbored the WAVE1 gene deletion.
Tambahkan Komentar